Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

It has been observed that acute stress causes the activation of TH1 cells, while TH2 cells regulate and act on chronic inflammation. Fibromyalgia (FM) is a chronic, idiopathic disorder which affects about twelve million people in the United States. FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep. The mechanism of induction of muscle pain and inflammation is not yet clear. In FM there is an increase in reactivity of central neurons with increased sensitivity localized mainly in the CNS. Mast cells are involved in FM by releasing proinflammatory cytokines, chemokines, chemical mediators, and PGD2. TNF is a cytokine generated by MCs and its level is higher in FM. The inhibition of pro-inflammatory IL-1 family members and TNF by IL-37 in FM could have a therapeutic effect. Here, we report for the first time the relationship between MCs, inflammatory cytokines and the new anti-inflammatory cytokine IL-37 in FM.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Biol. Regul. Homeost. Agents

Title: Journal of biological regulators and homeostatic agents

ISSN: 0393-974X

ISSN (Print): 0393-974X

Publication date (Electronic): April 25 2018

Volume: 32

Issue: 2

Affiliations

[1 ] Department of Medical Science and Biotechnology, University of Foggia, Foggia, Italy.

[2 ] Faculty of Parasitology, Aristotle University of Thessaloniki, Macedonia, Greece.

[3 ] UOS Clinica dei Pazienti del Territorio, Policlinico Gemelli, Rome, Italy.

[4 ] Department of Microbiology and Infectious Diseases, Aristotle University of Thessaloniki, Macedonia, Greece.

[5 ] Department of Medical and Morphological Science, University of Insubria, Varese, Italy.

[6 ] Department of Pharmacology, University of Perugia, Perugia, Italy.

[7 ] Section of Legal Medicine, Department of Medicine and Aging Sciences, University of Chieti-Pescara, Chieti, Italy.

[8 ] Department of Anesthesiology, ‘Santo Spirito’ Hospital, Pescara, Italy.

[9 ] Department of Biomedical Sciences and Specialist Surgery, Section of Ophthalmology, University of Ferrara, Italy.

[10 ] Immunology Division, Postgraduate Medical School, University of Chieti-Pescara, Chieti, Italy.

Article

Publisher Item ID: 1

PubMed ID: 29684996

SO-VID: 6e88f9b2-df0e-4074-9c7b-7f1da096e40b

History

Data availability:

Comments

Comment on this article

Cited by 17

See all cited by